Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Disease 3 Prostatic Neoplasms 2 Hereditary Cancer 2 Colorectal Neoplasms 2 Sarcoma, Kaposi 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pain 1 Neoplasms 1 Lung Neoplasms 1 Gynecologic Cancer 1 Genetic Diseases, Inborn 1 Development of the Virtual Biopsy 1 Colorectal Neoplasms, Hereditary Nonpolyposis 1 Colonic Neoplasms 1 Chronic Pain 1 Castleman Disease 1 Cancer Pain 1 COVID-19 1 Breast Neoplasms 1 Brain Neoplasms 1 Anus Neoplasms 1 Adenoma 1

Interventions

Standard of Care 8 Surveys and Questionnaires 7 COVID-19 Vaccines 6 Blood Specimen Collection 6 BNT162 Vaccine 6 Specimen Handling 5 2019-nCoV Vaccine mRNA-1273 5 Hydroxychloroquine 4 Surgical Procedures, Operative 3 Practice Guidelines as Topic 3 tocilizumab 2 sotrovimab 2 sinovac COVID-19 vaccine 2 cilgavimab and tixagevimab drug combination 2 Sodium Chloride 2 Pandemic Preparedness 2 Data Collection 2 CVnCoV COVID-19 vaccine 2 COH04S1 COVID-19 vaccine 2 Azithromycin 2 selinexor 1 remdesivir 1 regorafenib 1 proxalutamide 1 palbociclib 1 ogalvibart 1 monalizumab 1 lenzilumab 1 heterologous prime boost COVID-19 vaccination 1 crexavibart 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

COVID-19 × Diagnostic Tests, Routine × Clear all

NCT04421625 2025-12-30

PAPESCO-19

Institut Cancerologie de l'Ouest

Phase NA Completed

1,102 enrolled 4 charts

COVID-19

Data powered by HemOnc (CC BY 4.0) Colophon ⚡